Ronald See to Benzazepines
This is a "connection" page, showing publications Ronald See has written about Benzazepines.
Connection Strength
0.428
-
Dopamine D1 receptor antagonism in the prelimbic cortex blocks the reinstatement of heroin-seeking in an animal model of relapse. Int J Neuropsychopharmacol. 2009 Apr; 12(3):431-6.
Score: 0.298
-
Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology (Berl). 2001 Mar; 154(3):301-10.
Score: 0.043
-
In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacology. 1991 Dec; 30(12A):1269-74.
Score: 0.023
-
Effects of dopamine D1 and D2 receptor antagonists on oral activity in rats. Pharmacol Biochem Behav. 1989 Sep; 34(1):43-8.
Score: 0.019
-
Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors. Life Sci. 1989; 44(3):229-36.
Score: 0.018
-
Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats. Psychopharmacology (Berl). 1988; 96(2):253-7.
Score: 0.017
-
D1 and D2 dopamine receptor interactions with pilocarpine-induced oral activity in rats. Pharmacol Biochem Behav. 1989 Jul; 33(3):501-5.
Score: 0.005
-
The effects of D1 and D2 receptor antagonists on pain sensitivity and morphine analgesia in the rat. Proc West Pharmacol Soc. 1987; 30:229-32.
Score: 0.004